EUVIMEDEUVIMED entdecken
Crossref

Dendrobium officinale polysaccharide improves PMOS by regulating gut microbiota disorder

Zhi-Hao Ge, Hao-Ru Guan, Bo Li, Ze-Hua Zhang, Lu Li, Xuan-Nan Chen, Wan-Feng Xu, Xing-Li-Shang He, Ying-Jie Dong, Ping Wang, Gui-Yuan Lv, Su-Hong Chen

Traditional Medicine Research · 2027 · 12 (7) · 49

DOI: 10.53388/tmr2027049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Traditional Medicine Research, 2027. Verfasst von Zhi-Hao Ge und 11 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Polyglandular metabolic ovarian syndrome (PMOS) is a prevalent endocrine disorder in women, accompanied by reduced fertility, increased miscarriage risk, insulin resistance, obesity, and other metabolic abnormalities. Dendrobium officinale polysaccharide (DOCP) can regulate blood glucose and improve gastrointestinal health; however, its underlying mechanism against PMOS ‑ induced glucose and lipid metabolic disorders remains unclear. This study aimed to explore the ameliorative effects of DOCP on systemic lipid accumulation and chronic inflammation induced by intestinal barrier dysfunction in PMOS mice.

Methods

A PMOS mouse model was established via dehydroepiandrosterone injection combined with a high - fat and high - sugar diet for 28 days. Model mice were treated with Dendrobium officinale extract (DOE) or DOCP for 8 weeks, followed by the detection of serum sex hormones, metabolic parameters, tissue pathological damage, hepatic inflammatory factors, and gut microbiota composition.

Results

DOCP significantly improved hormonal and metabolic disorders, alleviated pathological injuries in the ovary, colon and liver, and downregulated the expression of IL - 6 and TNF ‑α in hepatic tissue. Furthermore, DOCP remodeled gut microbiota homeostasis, repaired intestinal barrier damage, and reduced systemic lipid accumulation.

Conclusion

In conclusion, DOCP ameliorates PMOS ‑ related hormonal and metabolic disturbances by regulating gut microbiota and inhibiting adipose ‑ derived inflammatory responses, indicating its promising clinical application for PMOS treatment.

Zitieren

APA

Ge, Z., Guan, H., Li, B., Zhang, Z., Li, L., Chen, X., Xu, W., He, X., Dong, Y., Wang, P., Lv, G., & Chen, S. (2027). Dendrobium officinale polysaccharide improves PMOS by regulating gut microbiota disorder. Traditional Medicine Research, 12(7), 49. https://doi.org/10.53388/tmr2027049

Vancouver

Ge Z, Guan H, Li B, Zhang Z, Li L, Chen X, et al. Dendrobium officinale polysaccharide improves PMOS by regulating gut microbiota disorder. Traditional Medicine Research. 2027;12(7):49. doi:10.53388/tmr2027049

BibTeX
@article{Ge2027,
  author = {Ge, Zhi-Hao and Guan, Hao-Ru and Li, Bo and Zhang, Ze-Hua and Li, Lu and Chen, Xuan-Nan and Xu, Wan-Feng and He, Xing-Li-Shang and Dong, Ying-Jie and Wang, Ping and Lv, Gui-Yuan and Chen, Su-Hong},
  title = {Dendrobium officinale polysaccharide improves PMOS by regulating gut microbiota disorder},
  journal = {Traditional Medicine Research},
  year = {2027},
  volume = {12},
  number = {7},
  pages = {49},
  doi = {10.53388/tmr2027049}
}
Kostenlos starten →